The weekly litigation news digest is live. Subscribe now

IP Verse

Phosphate-Free Pharmaceutical Composition For The Treatment Of Glaucoma - EP2429507

The patent EP2429507 was granted to Ursapharm Arzneimittel on Jul 19, 2017. The application was filed on May 14, 2010 under application number EP10723922A. The patent is currently recorded with a legal status of "Revoked".

EP2429507

URSAPHARM ARZNEIMITTEL
Application Number
EP10723922A
Filing Date
May 14, 2010
Status
Revoked
Jan 10, 2020
Publication Date
Jul 19, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
PHARMA STULLNApr 17, 2018JORG BERTEN -

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTDE102005055275
INTERNATIONAL-SEARCH-REPORTEP1312366
INTERNATIONAL-SEARCH-REPORTEP1985298
INTERNATIONAL-SEARCH-REPORTUS2001044467
INTERNATIONAL-SEARCH-REPORTUS2005276867
INTERNATIONAL-SEARCH-REPORTUS2008021101
INTERNATIONAL-SEARCH-REPORTWO0158866
INTERNATIONAL-SEARCH-REPORTWO2008096804
INTERNATIONAL-SEARCH-REPORTWO9853809
OPPOSITIONEP1985298
OPPOSITIONEP2123278
OPPOSITIONWO2007057201
OPPOSITIONWO2008096804
OPPOSITIONWO9853809

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents